Logo image of EBUS.AS

EBUSCO HOLDING NV (EBUS.AS) Stock Fundamental Analysis

AMS:EBUS - Euronext Amsterdam - NL0015002AG2 - Common Stock - Currency: EUR

0.621  -0.03 (-4.24%)

Fundamental Rating

2

Overall EBUS gets a fundamental rating of 2 out of 10. We evaluated EBUS against 106 industry peers in the Machinery industry. EBUS has a bad profitability rating. Also its financial health evaluation is rather negative. EBUS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EBUS had negative earnings in the past year.
EBUS had a negative operating cash flow in the past year.
In multiple years EBUS reported negative net income over the last 5 years.
EBUS had a negative operating cash flow in each of the past 5 years.
EBUS.AS Yearly Net Income VS EBIT VS OCF VS FCFEBUS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -50.80%, EBUS is not doing good in the industry: 93.40% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -120.90%, EBUS is doing worse than 89.62% of the companies in the same industry.
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROIC N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
EBUS.AS Yearly ROA, ROE, ROICEBUS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

1.3 Margins

EBUS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EBUS.AS Yearly Profit, Operating, Gross MarginsEBUS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

EBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EBUS has been increased compared to 1 year ago.
Compared to 5 years ago, EBUS has less shares outstanding
Compared to 1 year ago, EBUS has a worse debt to assets ratio.
EBUS.AS Yearly Shares OutstandingEBUS.AS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
EBUS.AS Yearly Total Debt VS Total AssetsEBUS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -1.89, we must say that EBUS is in the distress zone and has some risk of bankruptcy.
EBUS has a Altman-Z score of -1.89. This is amonst the worse of the industry: EBUS underperforms 82.08% of its industry peers.
EBUS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.11, EBUS belongs to the best of the industry, outperforming 85.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -1.89
ROIC/WACCN/A
WACC6.4%
EBUS.AS Yearly LT Debt VS Equity VS FCFEBUS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

EBUS has a Current Ratio of 1.30. This is a normal value and indicates that EBUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.30, EBUS is doing worse than 66.98% of the companies in the same industry.
A Quick Ratio of 0.56 indicates that EBUS may have some problems paying its short term obligations.
With a Quick ratio value of 0.56, EBUS is not doing good in the industry: 86.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.56
EBUS.AS Yearly Current Assets VS Current LiabilitesEBUS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

EBUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -224.81%.
EBUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.07%.
Measured over the past years, EBUS shows a very strong growth in Revenue. The Revenue has been growing by 36.83% on average per year.
EPS 1Y (TTM)-224.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%

3.2 Future

The Earnings Per Share is expected to grow by 19.94% on average over the next years. This is quite good.
Based on estimates for the next years, EBUS will show a very strong growth in Revenue. The Revenue will grow by 48.07% on average per year.
EPS Next Y-83.77%
EPS Next 2Y13.94%
EPS Next 3Y30.29%
EPS Next 5Y19.94%
Revenue Next Year-8.52%
Revenue Next 2Y6.37%
Revenue Next 3Y42.4%
Revenue Next 5Y48.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EBUS.AS Yearly Revenue VS EstimatesEBUS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EBUS.AS Yearly EPS VS EstimatesEBUS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 2 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EBUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EBUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EBUS.AS Price Earnings VS Forward Price EarningsEBUS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EBUS.AS Per share dataEBUS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as EBUS's earnings are expected to grow with 30.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.94%
EPS Next 3Y30.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EBUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EBUSCO HOLDING NV

AMS:EBUS (4/28/2025, 11:27:07 AM)

0.621

-0.03 (-4.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.96%
Inst Owner ChangeN/A
Ins Owners17.25%
Ins Owner ChangeN/A
Market Cap40.66M
Analysts38
Price Target1.54 (147.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)29.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)22.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-5.18
EYN/A
EPS(NY)-1.39
Fwd EYN/A
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.34
OCFYN/A
SpS1.51
BVpS1.87
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.11%
Cap/Sales 13.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.56
Altman-Z -1.89
F-Score1
WACC6.4%
ROIC/WACCN/A
Cap/Depr(3y)143.07%
Cap/Depr(5y)111.08%
Cap/Sales(3y)14.44%
Cap/Sales(5y)9.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-224.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
EPS Next Y-83.77%
EPS Next 2Y13.94%
EPS Next 3Y30.29%
EPS Next 5Y19.94%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%
Revenue Next Year-8.52%
Revenue Next 2Y6.37%
Revenue Next 3Y42.4%
Revenue Next 5Y48.07%
EBIT growth 1Y-76.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-36.95%
EBIT Next 3Y34.97%
EBIT Next 5Y29.69%
FCF growth 1Y-17.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.84%
OCF growth 3YN/A
OCF growth 5YN/A